These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Management of herpes simplex virus epithelial keratitis.
    Author: Roozbahani M, Hammersmith KM.
    Journal: Curr Opin Ophthalmol; 2018 Jul; 29(4):360-364. PubMed ID: 29697435.
    Abstract:
    PURPOSE OF REVIEW: To review recent advancements in the management of herpes simplex virus (HSV) epithelial keratitis. RECENT FINDINGS: Trifluridine eye drop, acyclovir (ACV) ointment, ganciclovir gel, and oral ACV are still the main therapeutic agents. Cryopreserved amniotic membrane has been recently used as an adjuvant treatment. Resistance to ACV has become a concerning issue. The animal models of HSV vaccine are able to reduce HSV keratitis. New antivirals are under development. SUMMARY: Current cases of HSV epithelial keratitis are manageable with available medications, but new advancements are required to decrease disease burden in the future. HSV vaccine can be revolutionary.
    [Abstract] [Full Text] [Related] [New Search]